Cargando…
Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada
OBJECTIVES: Intravenous immunoglobulin (IVIG) has demonstrated improvement in chronic inflammatory demyelinating polyneuropathy (CIDP) patients in placebo controlled trials. However, IVIG is also much more expensive than alternative treatments such as corticosteroids. The objective of the paper is t...
Autores principales: | Blackhouse, Gord, Gaebel, Kathryn, Xie, Feng, Campbell, Kaitryn, Assasi, Nazila, Tarride, Jean-Eric, O'Reilly, Daria, Chalk, Colin, Levine, Mitchell, Goeree, Ron |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903512/ https://www.ncbi.nlm.nih.gov/pubmed/20565778 http://dx.doi.org/10.1186/1478-7547-8-14 |
Ejemplares similares
-
Intravenous immunoglobulin for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis
por: Gaebel, Kathryn, et al.
Publicado: (2010) -
Cost-Effectiveness of Catheter Ablation for Rhythm Control of Atrial Fibrillation
por: Blackhouse, Gord, et al.
Publicado: (2013) -
Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
por: Xie, Feng, et al.
Publicado: (2009) -
Effects of study design and trends for EVAR versus OSR
por: Hopkins, Robert, et al.
Publicado: (2008) -
Loss of Schwann cell plasticity in chronic inflammatory demyelinating polyneuropathy (CIDP)
por: Joshi, Abhijeet R., et al.
Publicado: (2016)